Global Cell-Based Assays Market

Cell-Based Assays Market Size, Share, Growth Analysis, By Products & Services(Reagents, Assay Kits, Cell Growth Assays, Reporter Gene Assays), By Application(Basic Research, Drug Discovery, Other Applications), By End-Use(Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2154 | Region: Global | Published Date: March, 2024
Pages: 219 |Tables: 100 |Figures: 66

Cell-Based Assays Market Insights

Global Cell-Based Assays Market size was valued at USD 17.6 billion in 2022 and is poised to grow from USD 19.14 billion in 2023 to USD 37.44 billion by 2031, growing at a CAGR of 8.75% during the forecast period (2024-2031).

The global research landscape, including major clinical trials and drug discovery efforts, was profoundly disrupted by the COVID-19 pandemic. To address research backlogs, researchers worldwide swiftly adopted efficient and time-sensitive methodologies. Moreover, a multitude of cell-based assays were specifically developed for detecting COVID-19 infections, with several tests gaining FDA approval for global emergency use. An illustrative example is the T-Detect COVID-19 routine T-cell test (by Adaptive Biotechnologies), which obtained Emergency Use Authorization from the U.S. FDA in May 2021. This innovative Next-Generation Sequencing (NGS)-based test facilitates the identification of T-cells recognizing SARS-CoV-2 antigens, confirming recent infections.

Cell-based drug screening assays have played an integral role in drug discovery research, enabling the meticulous selection of promising drug candidates from vast compound libraries. The scope of these assays spans a diverse spectrum, influenced by multifaceted considerations in various drug development trajectories. Anticipated advancements in drug discovery hold promise for fostering an environment conducive to industry growth. A compelling instance is the groundbreaking development unveiled in September 2022 by Fraunhofer Institute researchers—Proxidrugs—a therapeutic prospect harnessing cell-based waste disposal systems to address conditions like infections, cancer, and Alzheimer's disease. This underscores the versatility of cell-based assays in driving scientific innovation and therapeutic evolution.

The market is currently poised for robust growth due to factors such as surging demand for drug discovery, an escalated requirement for biotechnology research, and the mounting incidence of infectious diseases, cancer, autoimmune disorders, and genetic anomalies. Cell-based assays play a pivotal role in the drug discovery process, not only for validating potential drug candidates but also for lead profiling, analyzing cellular signaling, and assessing toxicity. A prime example is The Annexin V-Cy3 apoptosis detection kit (by Cell Biologics), which leverages fluorescence to detect apoptosis—a testament to the diverse applications of these assays in comprehensive cellular analysis.

US Cell-Based Assays Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 17.6 billion

Largest Segment

Basic Research, Drug Discovery

Fastest Growth

Drug Discovery

Growth Rate

8.75% CAGR

Global Cell-Based Assays Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Cell-Based Assays Market Segmental Analysis

The global cell-based assays market is segmented on the basis of product & services, application, end - use, region. By product & services, the market is segmented into reagents, assay kits, cell growth assays, reporter gene assays, cell death assays, second messenger assays, microplates, probes & labels, instruments & software, cell lines, primary cell lines, stem cell lines, immortalized cell lines. By application, the market is segmented into basic research, drug discovery, other applications. By end – use, the market is segmented into pharmaceutical and biotechnology companies, academic & research institutes, contract research organizations. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Cell-Based Assays Market Analysis By Product

Remarkably, it was the consumables sector that commanded a prominent position, emerging as the driving force within this dynamic market landscape. This ascendancy can be traced back to a multifaceted interplay of influential dynamics that underscore the integral role of consumables.

The consumables segment's domination can be chiefly attributed to its indispensable role and recurrent utilization within the operational framework of pharmaceutical and biopharmaceutical entities. These organizations consistently draw upon consumables as fundamental requisites for their laboratory activities, particularly in the context of conducting diverse cell-based assays. The consumables' indispensability in the execution of these assays spans a spectrum of applications, encompassing drug screening, toxicity assessments, and intricate cellular analyses.

Cell-Based Assays Market Analysis By Application

Notably, it was the drug discovery application segment that held a commanding position, securing the largest share within the market landscape. This prominence is underpinned by a confluence of factors contributing to its robust growth trajectory.

The remarkable dominance of the drug discovery segment can be attributed to a dynamic interplay of key drivers. A notable driver is the escalating investments in research and development (R&D), which continue to inject vitality into the drug discovery domain. Additionally, the market is invigorated by ongoing technological innovations that bolster the efficiency and efficacy of supportive processes integral to drug discovery initiatives.

Furthermore, the introduction of novel pharmaceutical compounds fuels the demand for advanced cell-based assays, which play a pivotal role in assessing drug activity, toxicity, and efficacy. This vital contribution to enhancing the drug development pipeline positions the drug discovery segment as a pivotal growth engine.

Global Cell-Based Assays Market By Application, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Cell-Based Assays Market Regional Insights

North America stands as the dominant force globally, commanding a substantial market share, and this is attributed to its well-established healthcare sector and the widespread adoption of cell-based assays. The United States, in particular, showcases a robust healthcare landscape and a remarkable proclivity towards utilizing cell-based assays. Notably, the escalating prevalence of chronic diseases such as cancer, osteoarthritis, and diabetes within the United States fuels an augmented demand for cell-based assays, especially in the realm of pioneering drug discoveries. This phenomenon significantly contributes to the market's expansion, acting as a pivotal growth catalyst.

For instance, the recently published Cancer Facts & Figures 2022 data by the American Cancer Society provides a compelling illustration. This report underscores that the United States is projected to witness a staggering 1.9 million new cancer cases and an estimated 609,360 cancer-related deaths, reinforcing the pressing need for advanced tools like cell-based assays to facilitate groundbreaking research and therapeutic interventions.

Conversely, the Asia-Pacific region, while not surpassing North America, emerges as a noteworthy contender in the global cell-based assays market. This region exhibits a burgeoning interest in adopting these assays, fueled by escalating healthcare awareness, increasing research endeavors, and a mounting emphasis on personalized medicine. As Asia-Pacific forges ahead, the potential for growth and innovation within the realm of cell-based assays remains a captivating prospect, contributing to the evolving dynamics of the global healthcare landscape.

Global Cell-Based Assays Market By Geography, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Cell-Based Assays Market Dynamics

Cell-Based Assays Market Drivers

Rise in Chronic Diseases

  • The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders fuels the demand for advanced cell-based assays for disease modeling and drug testing.

Personalized Medicine Emphasis

  • Cell-based assays play a crucial role in personalized medicine by enabling tailored treatments based on individual patient responses, driving their integration into clinical decision-making.

Cell-Based Assays Market Restraints

Cost and Resource Intensiveness

  • Developing and conducting cell-based assays can be resource-intensive, with costs associated with reagents, equipment, and skilled personnel posing barriers, particularly for smaller research entities.

Complexity and Variability

  • The inherent complexity and variability of cellular systems can lead to challenges in assay reproducibility and standardization, affecting data quality and reliability.

Request Free Customization of this report to help us to meet your business objectives.

Cell-Based Assays Market Competitive Landscape

The competitive landscape of the global cell-based assays market is marked by intense innovation, strategic collaborations, and a focus on cutting-edge technology to meet the expanding demands of drug discovery, toxicology studies, and biomedical research. Industry leaders like Thermo Fisher Scientific, Merck KGaA, and PerkinElmer have established their dominance through a combination of advanced assay development, extensive product portfolios, and global reach.

Emerging players and biotechnology startups contribute to the landscape's dynamism, infusing novel methodologies and specialized assays. Collaborations between academia, pharmaceutical giants, and technology firms further enrich the competitive milieu, fostering cross-disciplinary expertise and accelerating assay advancements. The market is witnessing a shift toward personalized medicine and precision therapies, propelling the need for high-throughput, clinically relevant cell-based assays. Automation and data integration are key drivers, streamlining processes and enhancing assay reproducibility.

Cell-Based Assays Market Top Player’s Company Profiles

  • Thermo Fisher Scientific, Inc. (United States)
  • Promega Corporation (United States)
  • Merck KGaA (Germany)
  • PerkinElmer, Inc. (United States)
  • Danaher Corporation (United States)
  • Cell Signaling Technology, Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • GE Healthcare (United Kingdom)
  • Lonza Group Ltd. (Switzerland)

Cell-Based Assays Market Recent Developments

  • In August 2022, Life Net Health LifeSciences introduced the Cell-Based Assay Services.
  • In May 2022, The Aquios STEM system was introduced by Beckman Coulter Life Sciences to offer a fresh approach to stem cell analysis.

Cell-Based Assays Key Market Trends

  • 3D Cell Culture Advancements: The shift towards more physiologically relevant 3D cell culture models is gaining traction, allowing better recapitulation of in vivo conditions and enabling improved drug screening and toxicity assessment.
  • High-Content Screening (HCS) Growth: High-content screening techniques are becoming increasingly popular due to their ability to provide multi-parametric data from complex cell-based assays, enhancing understanding of cellular processes and disease mechanisms.

Cell-Based Assays Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global cell-based assays market analysis, the global cell-based assays market stands as a dynamic and rapidly evolving sector, driven by advancements in cellular research, drug discovery, and disease understanding. The widespread adoption of innovative technologies and the integration of automation have revolutionized the landscape, facilitating efficient and high-throughput experimentation. As pharmaceutical and biotechnology industries continue to seek targeted therapies and personalized medicine approaches, the demand for sophisticated cell-based assays remains robust. The market's growth is underpinned by the rising focus on precision medicine, drug safety assessment, and toxicology studies. Moreover, collaborative efforts between academia and industry are fostering the development of novel assays, enhancing the market's prospects.

Report Metric Details
Market size value in 2023 USD 17.6 billion
Market size value in 2031 USD 37.44 billion
Growth Rate 8.75%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Products & Services
    • Reagents, Assay Kits, Cell Growth Assays, Reporter Gene Assays, Cell Death Assays, Second Messenger Assays, Microplates, Probes & Labels, Instruments & Software, Cell Lines, Primary Cell Lines, Stem Cell Lines, Immortalized Cell Lines
  • Application
    • Basic Research, Drug Discovery, Other Applications
  • End-Use
    • Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Thermo Fisher Scientific, Inc. (United States)
  • Promega Corporation (United States)
  • Merck KGaA (Germany)
  • PerkinElmer, Inc. (United States)
  • Danaher Corporation (United States)
  • Cell Signaling Technology, Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • GE Healthcare (United Kingdom)
  • Lonza Group Ltd. (Switzerland)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Cell-Based Assays Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Cell-Based Assays Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Cell-Based Assays Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cell-Based Assays Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cell-Based Assays Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Cell-Based Assays Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cell-Based Assays Market size was valued at USD 17.6 billion in 2022 and is poised to grow from USD 19.14 billion in 2023 to USD 37.44 billion by 2031, growing at a CAGR of 8.75% during the forecast period (2024-2031).

The competitive landscape of the cell-based assays market is marked by intense innovation, strategic collaborations, and a focus on cutting-edge technology to meet the expanding demands of drug discovery, toxicology studies, and biomedical research. Industry leaders like Thermo Fisher Scientific, Merck KGaA, and PerkinElmer have established their dominance through a combination of advanced assay development, extensive product portfolios, and reach. 'Thermo Fisher Scientific, Inc. (United States)', 'Promega Corporation (United States)', 'Merck KGaA (Germany)', 'PerkinElmer, Inc. (United States)', 'Danaher Corporation (United States)', 'Cell Signaling Technology, Inc. (United States)', 'Bio-Rad Laboratories, Inc. (United States)', 'Agilent Technologies, Inc. (United States)', 'GE Healthcare (United Kingdom)', 'Lonza Group Ltd. (Switzerland)'

The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders fuels the demand for advanced cell-based assays for disease modeling and drug testing.

3D Cell Culture Advancements: The shift towards more physiologically relevant 3D cell culture models is gaining traction, allowing better recapitulation of in vivo conditions and enabling improved drug screening and toxicity assessment.

North America stands as the dominant force globally, commanding a substantial market share, and this is attributed to its well-established healthcare sector and the widespread adoption of cell-based assays. The United States, in particular, showcases a robust healthcare landscape and a remarkable proclivity towards utilizing cell-based assays. Notably, the escalating prevalence of chronic diseases such as cancer, osteoarthritis, and diabetes within the United States fuels an augmented demand for cell-based assays, especially in the realm of pioneering drug discoveries. This phenomenon significantly contributes to the market's expansion, acting as a pivotal growth catalyst.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cell-Based Assays Market

Product ID: SQMIG35H2154

$5,300
BUY NOW GET FREE SAMPLE